The US formulation focused contract manufacturing organisation (CMO) installed the equipment at its production facility in Largo, Florida to “allow products to move through the development stages on to commercialization within the same site.”
CoreRx also asserted that: “reducing the need for additional technology transfers and facilitating a faster time to market,” adding that “The expansion also builds upon the company’s existing controlled release, and multi-layer development capabilities.”
Manufacturing operations at the expanded facility are due to begin early next year.